The Role of TDP-43 in Alzheimer's Disease

被引:72
作者
Chang, Xiao-Long [1 ]
Tan, Meng-Shan [2 ]
Tan, Lan [1 ,2 ]
Yu, Jin-Tai [2 ,3 ]
机构
[1] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Peoples R China
[3] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
基金
中国国家自然科学基金;
关键词
TDP-43; A beta; Tau; Alzheimer's disease; Pathogenesis; Therapy; AMYOTROPHIC-LATERAL-SCLEROSIS; TAR-DNA-BINDING; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; MOUSE MODEL; PROTEIN; 43; MITOCHONDRIAL DYSFUNCTION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE;
D O I
10.1007/s12035-015-9264-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The transactive response DNA binding protein (TDP-43) has long been characterized as a main hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U, also known as FTLD-TDP). Several studies have indicated TDP-43 deposits in Alzheimer's disease (AD) brains and have robust connection with AD clinical phenotype. FTLD-U, which was symptomatically connected with AD, may be predictable for the comprehension of the role TDP-43 in AD. TDP-43 may contribute to AD through both beta-amyloid (A beta)-dependent and A beta-independent pathways. In this article, we summarize the latest studies concerning the role of TDP-43 in AD and explore TDP-43 modulation as a potential therapeutic strategy for AD. However, to date, little of pieces of the research on TDP-43 have been performed to investigate the role in AD; more investigations need to be confirmed in the future.
引用
收藏
页码:3349 / 3359
页数:11
相关论文
共 91 条
[61]   TAR-DNA binding protein-43 and alterations in the hippocampus [J].
Rauramaa, Tuomas ;
Pikkarainen, Maria ;
Englund, Elisabet ;
Ince, Paul G. ;
Jellinger, Kurt ;
Paetau, Anders ;
Alafuzoff, Irina .
JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (05) :683-689
[62]   TARDBP mutations in Parkinson's disease [J].
Rayaprolu, Sruti ;
Fujioka, Shinsuke ;
Traynor, Sharleen ;
Soto-Ortolaza, Alexandra I. ;
Petrucelli, Leonard ;
Dickson, Dennis W. ;
Rademakers, Rosa ;
Boylan, Kevin B. ;
Graff-Radford, Neill R. ;
Uitti, Ryan J. ;
Wszolek, Zbigniew K. ;
Ross, Owen A. .
PARKINSONISM & RELATED DISORDERS, 2013, 19 (03) :312-315
[63]   BETA-AMYLOID PROTEIN DEPOSITION IN THE BRAIN AFTER SEVERE HEAD-INJURY - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].
ROBERTS, GW ;
GENTLEMAN, SM ;
LYNCH, A ;
MURRAY, L ;
LANDON, M ;
GRAHAM, DI .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (04) :419-425
[64]   No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease [J].
Robinson, A. C. ;
Thompson, J. C. ;
Weedon, L. ;
Rollinson, S. ;
Pickering-Brown, S. ;
Snowden, J. S. ;
Davidson, Y. S. ;
Mann, D. M. A. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (07) :844-854
[65]   Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease [J].
Rohn, Troy T. .
BRAIN RESEARCH, 2008, 1228 :189-198
[66]   Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43) [J].
Romano, Maurizio ;
Buratti, Emanuele ;
Romano, Giulia ;
Klima, Raffaella ;
Belluz, Lisa Del Bel ;
Stuani, Cristiana ;
Baralle, Francisco ;
Feiguin, Fabian .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (10) :7121-7130
[67]   Mitochondrial Ca2+ Overload Underlies Aβ Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs [J].
Sanz-Blasco, Sara ;
Valero, Ruth A. ;
Rodriguez-Crespo, Ignacio ;
Villalobos, Carlos ;
Nunez, Lucia .
PLOS ONE, 2008, 3 (07)
[68]   Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis [J].
Sasaki, Shoichi ;
Takeda, Takahiro ;
Shibata, Noriyuki ;
Kobayashi, Makio .
NEUROSCIENCE LETTERS, 2010, 478 (02) :72-76
[69]   Is synaptic loss a unique hallmark of Alzheimer's disease? [J].
Scheff, Stephen W. ;
Neltner, Janna H. ;
Nelson, Peter T. .
BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) :517-528
[70]   Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease [J].
Sheng, Baiyang ;
Gong, Kai ;
Niu, Ying ;
Liu, Lingling ;
Yan, Yufang ;
Lu, Guangyuan ;
Zhang, Lihai ;
Hu, Min ;
Zhao, Nanming ;
Zhang, Xiufang ;
Tang, Peifu ;
Gong, Yandao .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (10) :1362-1375